Diagnosis of Amyloidosis: A Survey of Current Awareness and Clinical Challenges Among Cardiologists in Switzerland.

ABSTRACT:

Introduction

Transthyretin amyloidosis (ATTR) is a progressive disease in which amyloid fibril deposition disrupts tissue structure and organ function. Many patients with ATTR present with cardiac involvement; recent studies indicate that ATTR prevalence is higher than expected in patients with certain heart conditions. Although long delays to diagnosis are common, recent treatment advances have made timely diagnosis critical to ensure appropriate patient management. Despite clinical guideline updates, it remains unclear how these are being implemented in routine patient care.

Methods

We performed a survey of practicing cardiologists in Switzerland to assess their knowledge of ATTR and current clinical practice.

Results

Overall, 72 cardiologists completed the question

SUBMITTER: Mircsof D 

PROVIDER: S-EPMC7237604 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature